Isonipecotamides for the treatment of integrin-mediated disorders

Invention Grant

US07718673B2 Isonipecotamides for the treatment of integrin-mediated disorders 有权

Title translation: 用于治疗整联蛋白介导的疾病的异烟酰胺

Patent Title: Isonipecotamides for the treatment of integrin-mediated disorders
Patent Title (中): 用于治疗整联蛋白介导的疾病的异烟酰胺
Application No.: US10345808

Application Date: 2003-01-16
Publication No.: US07718673B2

Publication Date: 2010-05-18
Inventor: Michael J. Costanzo , William J. Hoekstra , Bruce E. Maryanoff
Applicant: Michael J. Costanzo , William J. Hoekstra , Bruce E. Maryanoff
Applicant Address: US NJ Raritan
Assignee: Ortho-McNeil Pharmaceutical, Inc.
Current Assignee: Ortho-McNeil Pharmaceutical, Inc.
Current Assignee Address: US NJ Raritan
Agent Yuriy P. Stercho
Main IPC: A61P9/00
IPC: A61P9/00 ; A61P19/10 ; A61K31/445 ; C07D211/00 ; C07D401/00 ; C07D405/00 ; C07D409/00

Abstract:

The invention is directed to novel isonipecotamide derivatives of Formula (I): which are useful in treating integrin-mediated disorders.

Abstract(Chinese):

本发明涉及式（I）的新型异哌耳酰胺衍生物：其可用于治疗整联蛋白介导的病症。

Public/Granted literature

Information query

Espacenet

IPC分类: